Aliases: CLN4, CLN4B, CSPA, NCL, mir-941-2, mir-941-3, mir-941-4, mir-941-5,DNAJC5
Chromosome No: 20
Chromosome Band: 20q13.33
Genetic Category: Rare single gene variant-Functional-Rare single gene variant/Functional
ASD Reports: 5
Recent Reports: 0
Annotated variants: 3
Associated CNVs: 4
Evidence score: 3
| Associated Disorders: |
|
Relevance to Autism
Chen et al., 2025 integrated cortex cell-specific cis-regulatory element annotations, a deep learning-based variant prediction model, and massively parallel reporter assays to systematically evaluate the functional impact of 227,878 non-coding de novo mutations (ncDNMs) in ASD probands from Simons Simplex Collection (SSC) and Autism Speaks MSSNG resource (MSSNG) cohorts and identified a ncDNM that down-regulated expression of the DNAJC5 gene in a MSSNG proband. A de novo loss-of-function variant and a de novo missense variant in DNAJC5 have also been identified in ASD probands (Yuen et al., 2017; Zhou et al., 2022). An epigenome-wide association study (EWAS) of the associations between prenatal exposure to phthalates, which has been associated with adverse health and neurodevelopmental outcomes, and DNA methylation in 152 maternal-infant pairs from the Alberta Pregnancy Outcomes and Nutrition (APrON) study in England-Mason et al., 2022 identified a Cytosine-phosphate-Guanine (Cpg) site (cg17343385) in DNAJC5 that associated with both high and low molecular weight phthalates in a venous buffy coat blood sample subset.
Molecular Function
This gene is a member of the J protein family. J proteins function in many cellular processes by regulating the ATPase activity of 70 kDa heat shock proteins. The encoded protein plays a role in membrane trafficking and protein folding, and has been shown to have anti-neurodegenerative properties. The encoded protein is known to play a role in cystic fibrosis and Huntington's disease. Heterozygous mutations in DNAJC5 are responsible for autosomal dominant Kufs-type neuronal ceroid lipofuscinosis 4 (CLN4; OMIM 162350), an autosomal dominant neurodegenerative disorder characterized by onset of symptoms in adulthood, including seizures, dementia, and behavioral and psychiatric manifestations (Velinov et al., 2012 and others).



